---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-028537"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-12-19T23:59:59+00:00"
generated_at: "2026-05-16T12:40:58.240343+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs signs non-binding LOI for reverse merger with ABL, ABL to become majority owner

## Summary
- ProPhase Labs (PRPH) entered a non-binding LOI for a reverse merger with Advanced Biological Laboratories S.A. (ABL), a European biotech firm.
- Under the proposal, ABL would become the majority owner of the combined entity.
- The LOI is non-binding; no definitive agreement or financial terms disclosed.

## SEC filing metadata
- accession: 0001493152-25-028537
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-12-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315225028537/0001493152-25-028537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315225028537/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-028537
- JSON: https://secwatch.observer/filing/0001493152-25-028537.json
- Plain text: https://secwatch.observer/filing/0001493152-25-028537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.